Mirikizumab: A New Therapeutic Option for the Treatment of Ulcerative Colitis

CONCLUSION: Mirikizumab provides a novel mechanism of action for the treatment of moderate to severe UC and is another welcomed treatment advance in the treatment arsenal, providing a more selective mechanism of action while maintaining a comparable safety profile.PMID:38344998 | DOI:10.1177/10600280241229742

Source: The Annals of Pharmacotherapy - February 12, 2024 Category: Drugs & Pharmacology Authors: David Choi Hilary Sheridan Shubha Bhat Source Type: research